EUVIMEDEUVIMED entdecken
Crossref

Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Aman Chauhan, Charles Kunos, Bhawana Konda, Heidi Weiss, Heloisa Soares, Daneng Li, MD, Thorvardur Halfdanarson,, Mary Mulcahy, Aman Khurana, Jan Beumer, William Carson und 7 weitere

Endocrine Abstracts · 04.03.2026

DOI: 10.1530/endoabs.116.c20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von Aman Chauhan und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chauhan, A., Kunos, C., Konda, B., Weiss, H., Soares, H., Li, D., MD, Halfdanarson,, T., Mulcahy, M., Khurana, A., Beumer, J., Carson, W., Rubinstein, L., Gore, S., Pelosof,, L., Ivy, P., Kohn, E., Anthony, L., & Arnold, S. (2026). Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.c20

Vancouver

Chauhan A, Kunos C, Konda B, Weiss H, Soares H, Li D, et al. Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.c20

BibTeX
@article{Chauhan2026,
  author = {Chauhan, Aman and Kunos, Charles and Konda, Bhawana and Weiss, Heidi and Soares, Heloisa and Li, Daneng and MD and Halfdanarson,, Thorvardur and Mulcahy, Mary and Khurana, Aman and Beumer, Jan and Carson, William and Rubinstein, Lawrence and Gore, Steven and Pelosof,, Lorraine and Ivy, Percy and Kohn, Elise and Anthony, Lowell and Arnold, Susanne},
  title = {Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)},
  journal = {Endocrine Abstracts},
  year = {2026},
  doi = {10.1530/endoabs.116.c20}
}
Kostenlos starten →